efavirenz and adam ii
efavirenz has been researched along with adam ii in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Buckheit, RW; Clercq, ED; Cullen, MD; Cushman, M; Deng, BL; Hartman, TL; Pannecouque, C; Watson, KM | 1 |
| Ashok, P; Chander, S; Sankaranarayanan, M; Wang, P; Yang, LM; Zheng, YT | 1 |
Other Studies
2 other study(ies) available for efavirenz and adam ii
| Article | Year |
|---|---|
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability.
Topics: Alkenes; Animals; Anti-HIV Agents; Benzoates; Cytopathogenic Effect, Viral; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Hydrolysis; Mutation; Nitriles; Oxadiazoles; Oxazoles; Rats; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Tetrazoles | 2007 |
Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone derivatives.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2017 |